Marker Therapeutics Inc (MRKR)
4.15
+0.05
(+1.22%)
USD |
NASDAQ |
May 17, 16:00
4.30
+0.15
(+3.61%)
After-Hours: 20:00
Marker Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2000 | 37.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
AIM ImmunoTech Inc | 81.54% |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 30.58% |
Electromed Inc | 74.85% |
Armata Pharmaceuticals Inc | -- |